Skip to main content
. 2023 Apr 20;11(4):871. doi: 10.3390/vaccines11040871

Table 1.

Main characteristics of the study population (n = 100).

Male, n (%) 83 (83)
Caucasians, n (%) 88 (88)
Age at HIV diagnosis (years), median (IQR) 36 (28–48)
Age at study enrollment (years), median (IQR) 54 (49–60)
Absolute number of CD4+ T cell count at nadir (cells/mm3), median (IQR) 258 (117–360)
Patients with <200 CD4+ T cell count at nadir, n (%) 36 (36)
Current CD4+ T cell count (cells/mm3), median (IQR) 580 (411–786)
Patients with suppressed undetectable plasma HIV RNA, n (%) 95 (95)
HIV RNA value in patients with detectable HIV viremia (copies/mL), median (IQR) 58 (49–72)